Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma (clinicaltrials.gov) - Oct 6, 2026 - P1 | N=20 | Recruiting | Sponsor: National Cancer Institute (NCI) | Suspended ➔ Recruiting
Enrollment open • Adult T-Cell Leukemia-Lymphoma • Follicular Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Peripheral T-cell Lymphoma • T Cell Non-Hodgkin Lymphoma
|